Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/06/20 → 31/12/23 |
Funding
- British Heart Foundation (PG/19/79/34742): £281,116.00
Generating Evidence that RABEP2 is a Novel GSK3 Substrate that Represents a Single Therapeutic Target to Reduce Both Hyperglycemia and Microvascular Disease in Diabetes (joint with Glasgow Uni)
- Kang, Li (Investigator)
- Khan, Faisel (Investigator)
- Murdoch, Colin (Investigator)
- Sutherland, Calum (Investigator)